Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 19;21(5):816-27.
doi: 10.1021/bc9005305.

Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy

Affiliations

Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy

Lalit N Goswami et al. Bioconjug Chem. .

Abstract

To develop novel bifunctional agents for tumor imaging (MR) and photodynamic therapy (PDT), certain tumor-avid photosensitizers derived from chlorophyll-a were conjugated with variable number of Gd(III)aminobenzyl DTPA moieties. All the conjugates containing three or six gadolinium units showed significant T(1) and T(2) relaxivities. However, as a bifunctional agent, the 3-(1'-hexyloxyethyl)pyropheophorbide-a (HPPH) containing 3Gd(III) aminophenyl DTPA was most promising with possible applications in tumor-imaging and PDT. Compared to HPPH, the corresponding 3- and 6Gd(III)aminobenzyl DTPA conjugates exhibited similar electronic absorption characteristics with a slightly decreased intensity of the absorption band at 660 nm. However, compared to HPPH, the excitation of the broad "Soret" band (near 400 nm) of the corresponding 3Gd(III)aminobenzyl-DTPA analogues showed a significant decrease in the fluorescence intensity at 667 nm.

PubMed Disclaimer

Figures

Scheme-1
Scheme-1
Scheme-2
Scheme-2
Scheme-3
Scheme-3
Scheme-4
Scheme-4
Scheme-5
Scheme-5
Figure 1
Figure 1
Comparative absorption (A) and fluorescence spectra (B) of HPPH and the corresponding 3 Gd(III)aminobenzyl DTPA 3 and 6Gd(III)aminobenzyl DTPA conjugate 15 in methanol (conc. 19.6 μM).
Figure 2
Figure 2
Comparative photobleaching characteristics of HPPH and the corresponding 3 and 6Gd(III) aminobenzyl DTPA 3 and 15 respectively at (9.8 M) in 17% BCS. The solutions were exposed with a laser light (500 mW, 665 nm, 75 mW/cm2) and the absorption peak at 665 nm were recorded at variable time points.
Figure 3
Figure 3
In vitro photosensitizing activity of photosensitizer-Gd(III)ADTPA conjugates (4.0 μM) in RIF cells. The cells were incubated for 24h and then exposed to light at a dose of 3.2 mW/cm2. Control cells were exposed to light only.
Figure 4
Figure 4
False-color images showing subcellular localization of HPPH and compound 3 (red) in Colon26 cells after 4h (B) or 24 h incubations (A and C) respectively. Localization was determined by fluorescence microscopy by co-incubation with fluorescent organelle probes (green). Subcellular areas of co-localization in the overlay of compound 3 or HPPH with the probes for are yellowish orange. A, HPPH; B and C, compound 3; D, MitoTracker Green; E and F, Bodipy ceramide C5-albumin complex; G, overlay of HPPH and MitoTracker Green; H and I overlays of compound 3 and Bodipy ceramide C5-albumin complex

Similar articles

Cited by

References

    1. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics and applications. Chem. Rev. 1999;99:2293–2352. - PubMed
    1. Kolokythas O, Shibata DK, Dubinsky TJ. In: Medical Imaging in Image-Guided Therapy Systems. Vaezy S, Zderic V, editors. Artech House; Boston: 2009. pp. 17–57.
    1. Hamblin MR, Mroz P, editors. Advances in Photodynamic Therapy. Artech House; Norwood MA: 2008.
    1. Carpenter CM, Pogue BW. In: Difuse Optical Spectroscopy with Magnetic Resonance Imaging in Translational Multimodality Optical Imaging. Azar FS, Intes X, editors. Artech House; Boston: 2008. pp. 125–162.
    1. Povoski SP, Hall NC, Marin EW, Walker MJ. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in case of occult recurrent metastatic melanoma. World J. Surg. Oncol. 2008;6:1. - PMC - PubMed

Publication types

MeSH terms